{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:35:11Z","timestamp":1790120111111,"version":"4.0.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","onlinecjc.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cjca.2023.12.001","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T03:43:12Z","timestamp":1702006992000},"page":"833-842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interventions in Hypertrophic Obstructive Cardiomyopathy"],"prefix":"10.1016","volume":"40","author":[{"given":"Wern Yew","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed N.","family":"Meah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Stables","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2023.12.001_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pcad.2006.08.001","article-title":"Pathophysiology and treatment of hypertrophic cardiomyopathy","volume":"49","author":"Sherrid","year":"2006","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2023.12.001_bib2","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.CIR.36.6.852","article-title":"Angiographic anatomy of the left ventricle and mitral valve in idiopathic hypertrophic subaortic stenosis","volume":"36","author":"Simon","year":"1967","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.12.001_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.110.985812","article-title":"Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy","volume":"124","author":"Maron","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.12.001_bib4","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.84.3.1188","article-title":"Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction","volume":"84","author":"Klues","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.12.001_bib5","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.12.001_bib6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacc.2021.11.021","article-title":"Management of hypertrophic cardiomyopathy: JACC State-of-the-Art Review","volume":"79","author":"Maron","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.12.001_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCRESAHA.119.315159","article-title":"Paradigm of sudden death prevention in hypertrophic cardiomyopathy","volume":"125","author":"Maron","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2023.12.001_bib9","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.amjcard.2013.02.040","article-title":"Risk of death in long-term follow-up of patients with apical hypertrophic cardiomyopathy","volume":"111","author":"Klarich","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib10","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.12.001_bib11","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/j.jacc.2020.08.044","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib12","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jacc.2018.06.054","article-title":"Exercise training for patients with hypertrophic cardiomyopathy: JACC Review Topic of the Week","volume":"72","author":"Dias","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2047487313501277","article-title":"Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation center","volume":"22","author":"Klempfner","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib14","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.2017.2503","article-title":"Effect of moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: a randomized clinical trial","volume":"317","author":"Saberi","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.12.001_bib15","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1161\/CIRCULATIONAHA.117.030616","article-title":"Population burden of sudden death associated with hypertrophic cardiomyopathy","volume":"136","author":"Aro","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.12.001_bib16","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa1510687","article-title":"A\u00a0prospective study of sudden cardiac death among children and young adults","volume":"374","author":"Bagnall","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.12.001_bib17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.amjmed.2015.12.027","article-title":"Hypertrophic cardiomyopathy as a cause of sudden cardiac death in the young: a meta-analysis","volume":"129","author":"Ullal","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2023.12.001_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.003454","article-title":"Clinical profile of athletes with hypertrophic cardiomyopathy","volume":"8","author":"Sheikh","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2023.12.001_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jamacardio.2023.1042","article-title":"Vigorous exercise in patients with hypertrophic cardiomyopathy","volume":"8","author":"Lampert","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.CIR.97.1.41","article-title":"Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy","volume":"97","author":"Sherrid","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.12.001_bib21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.amjcard.2010.06.059","article-title":"Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline","volume":"106","author":"Kajimoto","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1573403X1201160126125403","article-title":"Drug therapy for hypertrophic cardiomypathy: physiology and practice","volume":"12","author":"Sherrid","year":"2016","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.cjca.2023.12.001_bib23","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/S0140-6736(21)00763-7","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"397","author":"Spertus","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.12.001_bib24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.12.001_bib25","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/CIRCULATIONAHA.122.062534","article-title":"Dose-blinded myosin inhibition in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy: outcomes through 32 weeks","volume":"147","author":"Desai","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.12.001_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00000658-196108000-00003","article-title":"Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy","volume":"154","author":"Morrow","year":"1961","journal-title":"Ann Surg"},{"key":"10.1016\/j.cjca.2023.12.001_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/hrt.22.3.403","article-title":"Obstructive cardiomyopathy simulating aortic stenosis","volume":"22","author":"Goodwin","year":"1960","journal-title":"Br Heart J"},{"key":"10.1016\/j.cjca.2023.12.001_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCULATIONAHA.112.000849","article-title":"Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction","volume":"128","author":"Desai","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.12.001_bib29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jchf.2014.06.012","article-title":"Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy","volume":"2","author":"Vriesendorp","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2023.12.001_bib30","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/eurheartj\/ehm117","article-title":"Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy","volume":"28","author":"McLeod","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.12.001_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjcard.2019.09.029","article-title":"Efficacy of combined Cox-Maze IV and ventricular septal myectomy for treatment of atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy","volume":"125","author":"Boll","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacc.2023.05.052","article-title":"First-in-human transapical beating-heart septal myectomy in patients with hypertrophic obstructive cardiomyopathy","volume":"82","author":"Fang","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib33","first-page":"I191","article-title":"Results of operation for hypertrophic obstructive cardiomyopathy in children and adults less than 40 years of age","volume":"80","author":"Mohr","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.12.001_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjcard.2021.09.040","article-title":"Outcomes over follow-up \u2265 10 years after surgical myectomy for symptomatic obstructive hypertrophic cardiomyopathy","volume":"163","author":"Maron","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib94","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pcad.2023.06.001","article-title":"Patient reported outcomes in obstructive hypertrophic cardiomyopathy undergoing myectomy: results from SPIRIT-HCM study","volume":"80","author":"Tower-Rader","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2023.12.001_bib35","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jacc.2011.08.040","article-title":"Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment","volume":"58","author":"Ball","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib36","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamacardio.2016.0252","article-title":"Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US Nationwide Inpatient Database, 2003-2011","volume":"1","author":"Kim","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib37","article-title":"Hospital procedural volume and clinical outcomes following septal reduction therapy in obstructive hypertrophic cardiomyopathy","volume":"12","author":"Altibi","year":"2023","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2023.12.001_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2018.01.130","article-title":"Outcomes following the surgical management of left ventricular outflow tract obstruction; a systematic review and meta-analysis","volume":"265","author":"Collis","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib39","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ejcts.2009.03.049","article-title":"Sustained improvement after combined anterior mitral valve leaflet retention plasty and septal myectomy in preventing systolic anterior motion in hypertrophic obstructive cardiomyopathy in children","volume":"36","author":"Delmo Walter","year":"2009","journal-title":"Eur J Cardiothoracic Surg"},{"key":"10.1016\/j.cjca.2023.12.001_bib40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0735-1097(96)00103-9","article-title":"Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy","volume":"28","author":"Kofflard","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib41","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jacc.2016.01.071","article-title":"The mitral valve in obstructive hypertrophic cardiomyopathy: a test in context","volume":"67","author":"Sherrid","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib42","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jacc.2016.07.735","article-title":"Mitral regurgitation in patients with hypertrophic obstructive cardiomyopathy: implications for concomitant valve procedures","volume":"68","author":"Hong","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000454800","article-title":"The use of MitraClip for symptomatic patients with hypertrophic obstructive cardiomyopathy","volume":"137","author":"Thomas","year":"2017","journal-title":"Cardiology"},{"key":"10.1016\/j.cjca.2023.12.001_bib44","first-page":"E228","article-title":"Use of MitraClip to target obstructive SAM in severe diffuse-type hypertrophic cardiomyopathy: case report and review of literature","volume":"32","author":"Long","year":"2020","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib45","first-page":"47","article-title":"Hypertrophic obstructive cardiomyopathy","volume":"116","author":"Batzner","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.cjca.2023.12.001_bib46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","article-title":"Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy","volume":"346","author":"Sigwart","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.12.001_bib47","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.amjcard.2004.10.050","article-title":"Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes","volume":"95","author":"Veselka","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib48","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cjca.2011.09.001","article-title":"Long-term effects of varying alcohol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy: a randomized study with a follow-up up to 11 years","volume":"27","author":"Veselka","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib49","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/CIRCRESAHA.116.309348","article-title":"Hypertrophic obstructive cardiomyopathy: surgical myectomy and septal ablation","volume":"121","author":"Nishimura","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2023.12.001_bib50","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0038-1675213","article-title":"Results of ten-year follow-up of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy","volume":"27","author":"Kashtanov","year":"2018","journal-title":"Int J Angiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/europace\/euv302","article-title":"Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound\u00ae technology to guide ablation","volume":"18","author":"Cooper","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2023.12.001_bib52","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12928-019-00574-0","article-title":"Utility of preprocedural multidetector computed tomography in alcohol septal ablation for hypertrophic obstructive cardiomyopathy","volume":"34","author":"Yanagiuchi","year":"2019","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.cjca.2023.12.001_bib53","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1002\/ccd.24328","article-title":"Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"81","author":"Sorajja","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.12.001_bib54","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.jcin.2021.03.066","article-title":"Sex-related differences in outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy","volume":"14","author":"Veselka","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.12.001_bib55","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/eurheartj\/eht495","article-title":"Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population","volume":"35","author":"Veselka","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.12.001_bib56","first-page":"E769","article-title":"Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a 16-year experience","volume":"33","author":"Fernandes","year":"2021","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib57","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1038\/s41598-017-10144-0","article-title":"Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China","volume":"7","author":"An","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cjca.2023.12.001_bib58","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.jcin.2022.06.034","article-title":"Outcomes of patients with hypertrophic obstructive cardiomyopathy and pacemaker implanted after alcohol septal ablation","volume":"15","author":"Veselka","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.12.001_bib59","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jcin.2017.03.030","article-title":"Outcomes of alcohol septal ablation in younger patients with obstructive hypertrophic cardiomyopathy","volume":"10","author":"Liebregts","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.12.001_bib60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ccd.29478","article-title":"Predicting complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy using a risk stratification model and clinical tool","volume":"98","author":"Karimianpour","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.12.001_bib61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ccd.26293","article-title":"A\u00a0meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy","volume":"88","author":"Singh","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.12.001_bib62","first-page":"3062","article-title":"Alcohol septal ablation versus septal myectomy treatment of obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"9","author":"Byty\u00e7i","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cjca.2023.12.001_bib63","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezad043","article-title":"Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis","volume":"63","author":"Yokoyama","year":"2023","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2023.12.001_bib64","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jtcvs.2018.08.062","article-title":"Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a propensity score-matched cohort","volume":"157","author":"Nguyen","year":"2019","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2023.12.001_bib65","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cjca.2023.06.417","article-title":"Outcomes of alcohol septal ablation in patients with severe left ventricular outflow tract obstruction: a propensity score matching analysis","volume":"39","author":"Veselka","year":"2023","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib66","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.5114\/aoms.2020.97969","article-title":"Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry","volume":"16","author":"Veselka","year":"2020","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.cjca.2023.12.001_bib67","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjcard.2022.08.028","article-title":"Prediction of sudden cardiac arrest after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: ASA-SCARRE risk score","volume":"184","author":"Veselka","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib68","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/ccd.26668","article-title":"Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy","volume":"88","author":"Guerrero","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2023.12.001_bib69","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/eurheartj\/ehm632","article-title":"Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up","volume":"29","author":"Durand","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.12.001_bib70","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4244\/EIJV6I7A151","article-title":"Substitution of ethanol with specially designed microspheres in a TASH procedure","volume":"6","author":"Latsios","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cjca.2023.12.001_bib71","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12471-013-0393-z","article-title":"Microsphere embolisation as an alternative for alcohol in percutaneous transluminal septal myocardial ablation","volume":"21","author":"Vriesendorp","year":"2013","journal-title":"Neth Heart J"},{"key":"10.1016\/j.cjca.2023.12.001_bib72","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.amjcard.2023.06.006","article-title":"Septal microsphere embolization in hypertrophic obstructive cardiomyopathy","volume":"201","author":"Alyaydin","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib73","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.amjcard.2005.07.073","article-title":"Usefulness of tissue Doppler imaging for demonstrating altered septal contraction sequence during dual-chamber pacing in obstructive hypertrophic cardiomyopathy","volume":"96","author":"Ito","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib74","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0140-6736(92)91961-7","article-title":"Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy","volume":"339","author":"Jeanrenaud","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.12.001_bib75","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.recesp.2015.08.022","article-title":"Sequential atrioventricular pacing in patients with hypertrophic cardiomyopathy: an 18-year experience","volume":"69","author":"Jurado Rom\u00e1n","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.cjca.2023.12.001_bib76","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0002-9149(98)01065-0","article-title":"Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy","volume":"83","author":"Linde","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib77","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1161\/01.CIR.99.22.2927","article-title":"Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)","volume":"99","author":"Maron","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.12.001_bib78","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1540-8167.2007.00763.x","article-title":"Resynchronization or dyssynchronization--successful treatment with biventricular stimulation of a child with obstructive hypertrophic cardiomyopathy without dyssynchrony","volume":"18","author":"Lenarczyk","year":"2007","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib79","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.hrthm.2010.10.010","article-title":"Biventricular pacing in hypertrophic obstructive cardiomyopathy: a pilot study","volume":"8","author":"Berruezo","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2023.12.001_bib80","first-page":"5","article-title":"Initial experience of a cohort of patients with hypertrophic cardiomyopathy undergoing biventricular pacing","volume":"11","author":"Rinaldi","year":"2011","journal-title":"Indian Pacing Electrophysiol J"},{"key":"10.1016\/j.cjca.2023.12.001_bib81","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.12.001_bib82","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","article-title":"Enhanced American College of Cardiology\/American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy","volume":"4","author":"Maron","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib83","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A\u00a0novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.12.001_bib84","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.12.001_bib85","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.008123","article-title":"Long-term outcome in high-risk patients with hypertrophic cardiomyopathy after primary prevention defibrillator implants","volume":"13","author":"Rowin","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib86","first-page":"493","article-title":"Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy","volume":"93","author":"Lawrenz","year":"2004","journal-title":"Z\u00a0Kardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib87","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2010.07.055","article-title":"Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months\u2019 follow-up in 19 patients","volume":"57","author":"Lawrenz","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib88","first-page":"448","article-title":"Radiofrequency catheter septal ablation for hypertrophic obstructive cardiomyopathy in children","volume":"13","author":"Emmel","year":"2005","journal-title":"Netherlands Heart J"},{"key":"10.1016\/j.cjca.2023.12.001_bib89","first-page":"284","article-title":"Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy [in Chinese]","volume":"47","author":"Liu","year":"2019","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.cjca.2023.12.001_bib90","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jcu.22989","article-title":"Clinical value of 2D speckle tracking imaging in evaluating the effect of percutaneous intramyocardial septal radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy","volume":"49","author":"Qian","year":"2021","journal-title":"J\u00a0Clin Ultrasound"},{"key":"10.1016\/j.cjca.2023.12.001_bib91","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.jacc.2018.07.080","article-title":"Percutaneous intramyocardial septal radiofrequency ablation for hypertrophic obstructive cardiomyopathy","volume":"72","author":"Liu","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib92","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jelectrocard.2020.06.013","article-title":"Electrocardiographic QRS voltage amplitude improvement by intramyocardial radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy and one year follow up","volume":"61","author":"Zuo","year":"2020","journal-title":"J\u00a0Electrocardiol"},{"key":"10.1016\/j.cjca.2023.12.001_bib93","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamacardio.2022.0259","article-title":"Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy","volume":"7","author":"Zhou","year":"2022","journal-title":"JAMA Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23019712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23019712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T13:48:30Z","timestamp":1715694510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X23019712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0828282X23019712"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2023.12.001","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interventions in Hypertrophic Obstructive Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2023.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}